Berthold F - Search Results

1

Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease.

Oberthuer A, Warnat P, Kahlert Y, Westermann F, Spitz R, Brors B, Hero B, Eils R, Schwab M, Berthold F, Fischer M. Oberthuer A, et al. Among authors: berthold f. Cancer Lett. 2007 Jun 8;250(2):250-67. doi: 10.1016/j.canlet.2006.10.016. Epub 2006 Nov 28. Cancer Lett. 2007. PMID: 17126996

2

Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.

Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J. Berthold F, et al. Eur J Cancer. 1992;28A(12):1950-4. doi: 10.1016/0959-8049(92)90234-s. Eur J Cancer. 1992. PMID: 1419287

3

Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma.

Becker K, Berthold F. Becker K, et al. Among authors: berthold f. Pediatr Hematol Oncol. 1992 Jul-Sep;9(3):269-72. doi: 10.3109/08880019209016595. Pediatr Hematol Oncol. 1992. PMID: 1525006

4

Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.

Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul FD, Waters W, Wehinger H, Niethammer D. Klingebiel T, et al. Among authors: berthold f. Med Pediatr Oncol. 1991;19(2):84-8. doi: 10.1002/mpo.2950190203. Med Pediatr Oncol. 1991. PMID: 2011100

5

Neuroblastoma consensus deletion maps to 1p36.1-2.

Weith A, Martinsson T, Cziepluch C, Brüderlein S, Amler LC, Berthold F, Schwab M. Weith A, et al. Among authors: berthold f. Genes Chromosomes Cancer. 1989 Nov;1(2):159-66. doi: 10.1002/gcc.2870010209. Genes Chromosomes Cancer. 1989. PMID: 2487156

6

[Neuroblastoma: diagnosis and therapy].

Wargalla-Plate U, Hero B, Berthold F. Wargalla-Plate U, et al. Among authors: berthold f. Praxis (Bern 1994). 1995 Oct 10;84(41):1152-7. Praxis (Bern 1994). 1995. PMID: 7481325 German.

7

Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma.

Christiansen H, Sahin K, Berthold F, Hero B, Terpe HJ, Lampert F. Christiansen H, et al. Among authors: berthold f. Eur J Cancer. 1995;31A(4):541-4. doi: 10.1016/0959-8049(95)00030-m. Eur J Cancer. 1995. PMID: 7576963

8

The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.

Gehring M, Berthold F, Edler L, Schwab M, Amler LC. Gehring M, et al. Among authors: berthold f. Cancer Res. 1995 Nov 15;55(22):5366-9. Cancer Res. 1995. PMID: 7585602

9

The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.

Berthold F, Hero B, Breu H, Christiansen H, Erttmann R, Gnekow A, Herrmann F, Klingebiel T, Lampert F, Müller-Weihrich S, Weinel P. Berthold F, et al. Ann Oncol. 1996 Feb;7(2):183-7. doi: 10.1093/oxfordjournals.annonc.a010547. Ann Oncol. 1996. PMID: 8777176 Free article.

10

[Hepatopathy in patients with stage 4S neuroblastoma].

Claviez A, Hero B, Schneppenheim R, Berthold F. Claviez A, et al. Among authors: berthold f. Klin Padiatr. 1996 Jul-Aug;208(4):221-8. doi: 10.1055/s-2008-1046477. Klin Padiatr. 1996. PMID: 8926687 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters